 eFFECTOR Therapeutics Inc NASDAQ: EFTR, in collaboration with Baylor College of Medicine, announced the presentation of new positive data for zotatifin in animal models of triple-negative breast cancer TNBC. The data were at the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. 